(Q33668831)

28 July 2017

1 reference

title

Clinically significant pharmacokinetic drug interactions between antiepileptic drugs (English)

1 reference

28 July 2017

1 reference

Tanaka E

1

1 reference

28 July 2017

publication date

1 April 1999

1 reference

Journal of Clinical Pharmacy and Therapeutics

28 July 2017

published in

1 reference

28 July 2017

volume

24

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

87-92

1 reference

Cytochrome P450 isozymes and antiepileptic drug interactions

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

A mechanistic approach to antiepileptic drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Monitoring blood levels of selected drugs. Remember to factor in the many confounding variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Antiepileptic drug therapy in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Genetic polymorphism of S-mephenytoin hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Polymorphic hydroxylation of Debrisoquine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

The drug interaction potential of ranitidine: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Lamotrigine clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Valproate may lower serum-phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00201.X

10.1046/J.1365-2710.1999.00201.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference